News

Dear partners, The health and wellbeing of our staff, customers and partners is a priority for all of us at GC Aesthetics. We recognise that this is an exceptional time of uncertainty and rapid change for everyone in our global community. Within GC Aesthetics our...

Dublin, Ireland – 4 September 2019 – GC Aesthetics (GCA), a global medical technology company with over 40 years of experience, is pleased to announce that it has become a Gold Sponsor of the International Society of Aesthetic Plastic Surgery (ISAPS). GCA is committed...

The Australian Therapeutic Good Administration (TGA) has released a public statement of the preliminary outcomes from its review of textured implants on July 11, 2019. The notice proposes certain actions the TGA may take in relation to textured implants used in...

Dublin, Ireland – June 20, 2019 – GC Aesthetics, Inc. (GCA), a privately-held medical technology company providing aesthetic solutions for global healthcare markets, announced today that the Company will be launching two new products. The first product, Eve 4.0, will...

GC Aesthetics (GCA) announced today that data from a European clinical study of over 500 women implanted with the GC Aesthetics’ Eurosilicone breast implants was published online on the April 27, 2019 in Aesthetic Surgery Journal Open Forum. The study, titled...

Following recent concerns that have been raised about a possible connection between textured breast implants and the rare condition known as anaplastic large cell lymphoma (BIA-ALCL), the French government agency responsible for medicines and health products (ANSM)...

GC Aesthetics (“GCA”), a medical technology company providing healthcare aesthetic solutions for global healthcare markets, announced today several recent positive developments for the Company, demonstrating continued progress on its U.S. and international growth...

GC Aesthetics (“GCA”), a medical technology company providing aesthetic solutions for global healthcare markets, announced today that the company has raised $97 million of new capital. The financing comprises a combination of debt, provided by Hayfin Capital...

Breast Augmentation is the most popular cosmetic surgery treatment in the world. As the number of augmentations continues to rise, safety has never been more important. With a strong commitment to setting the ‘Gold Standard’ in care, quality and safety for patients...

Dublin – 23rd of February 2017 – A leading global breast implant manufacturer has today announced that it will be funding research into the socio-economic impact of breast cancer diagnoses. GC Aesthetics, a leading medical aesthetics and breast implant company, is...

GC Aesthetics, a leading global breast implant company today announces the introduction of its fastest-growing, innovative products IMPLEO and The Matrix to Brazil, the largest breast implant market globally outside the US. Both products will be launched to the...

Dublin – 3rd October 2016 – A leading global breast implant manufacturer has today announced it will deliver a series of scientific lectures in partnership with an internationally acclaimed plastic surgeon. GC Aesthetics, which is fast becoming the number one selling...